AgomAb Therapeutics NV (AGMB) Goodwill (2023 - 2026)
Agomab Therapeutics (AGMB) recorded Goodwill of $10.01 million in Q2 2026.
Powered by 
Analysis
AgomAb Therapeutics NV (AGMB) Goodwill (2023 - 2026) Analysis & Trends
At the end of FY2025, Agomab Therapeutics reported Goodwill of $9.73 million, up 4.4% from FY2024.
- Across earlier years, Goodwill came in at $9.32 million in FY2024 (+0.1%) and $9.32 million in FY2023.
- The Q2 2026 figure is the lowest quarterly Goodwill since Q4 2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.84 Mn |
| Dec 31, 2025 | 10.12 Mn |
| Dec 31, 2024 | 8.96 Mn |
| Dec 31, 2023 | 9.53 Mn |
API Access
AgomAb Therapeutics NV Goodwill API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=goodwill&ticker=AGMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "goodwill", "ticker": "AGMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=goodwill&ticker=AGMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();